Alternatives to TippingPoint Biosciences
TippingPoint Biosciences is a Biotech tool: developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to TippingPoint Biosciences
- Website
Adicet Bio48BiotechBoston, United States$389.0MClinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
- Website MOMorphic Holding10SoftwareNew York, United States
Morphic Holding is a holding company focused on acquiring and operating software businesses.
- Website
BeiGene65BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Caris Life Sciences59BiotechIrving, United States$700.0MCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
- Website
Hexagon Bio57BiotechMenlo Park, United States$100.0MDeveloping novel therapeutics by understanding the complex interplay of biological systems.
- Website
Guardant Health57BiotechRedwood City, United States$900.0MGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
- Website PRProNAi Therapeutics55Biotech$115.8M
A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.
- Website
Adaptam Therapeutics53BiotechCambridge, United States$4.7MDeveloping novel therapeutics for rare genetic diseases with a focus on protein degradation.
- Website CSCSF Biosciences48BiotechCambridge, United States$15.0M
Develops novel protein engineering and directed evolution technologies for therapeutic discovery.
- Website
Dren Bio48BiotechSan Carlos, United States$156.0MBiopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.
- Website ONOneThree Biotech45BiotechNew York City, United States$2.8M
AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.
- Website
AbCellera41BiotechVancouver, Canada$10.0MAI-powered platform for antibody discovery and development to create new medicines.
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website
Sutro Biopharma40BiotechSouth San Francisco, United States$296.4MClinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.
- Website OMOmega Therapeutics61BiotechCambridge, United States
Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.
- Website
Mabylon35BiotechGeneva, Switzerland$35.8MMabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.
- Website
Amgen34BiotechThousand Oaks, United States$40.0MA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Showing the 20 closest matches. See the rest on the TippingPoint Biosciences profile.